3月21日,心泰医疗(02291)发布公告,预告2024年度公司归母净利润约为2.3亿元至2.6亿元,而2023年度的归母净利润为1.52亿元。
公司归母净利润增加主要原因为生物可降封堵器系列产品2024年度销量同比大幅增加。
(文章来源:财中社)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.